EYE 0.00% 21.0¢ nova eye medical limited

On Track to Profitability, Price Target Increased (MST), page-66

  1. 1,212 Posts.
    lightbulb Created with Sketch. 77
    iStent does look pretty easy to insert and easy to pitch, the need to put multiple so they won't get blocked is an issue but easy to say, just in case since the things are so small. No lasting damage and improved drainage is a good sell point for iTrack. Honestly the biggest drawback is the need/want of proctoring to learn how to do the procedures. Should be less of an issue with time and why they are investing in taking their operators around to talk about the procedures and how to perform them.

    iStent is like 25x the sales though, iTrack advance sales are a rounding error, most users for iTrack advance had used iTrack I believe originally at first so there would be far less combination procedures as it was a convoluted procedure before. Combo MIGS would be less likely as these are physicians doing a less profitable procedure because they think it is even though it is going to earn them less money or because then they can say they have another skill in the toolset
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $48.10M
Open High Low Value Volume
21.0¢ 21.3¢ 21.0¢ $4.002K 18.99K

Buyers (Bids)

No. Vol. Price($)
2 123170 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 190333 2
View Market Depth
Last trade - 15.09pm 03/09/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.